Latest News about SUPN
Recent news which mentions SUPN
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
April 16, 2021
From Benzinga
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
April 15, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
April 14, 2021
From Benzinga
From Benzinga
54 Biggest Movers From Yesterday
April 06, 2021
From Benzinga
35 Stocks Moving In Monday's Mid-Day Session
April 05, 2021
From Benzinga
25 Stocks Moving in Monday's Pre-Market Session
April 05, 2021
From Benzinga
These 2 Scrappy Biotechs Could Skyrocket in April
April 04, 2021
From Motley Fool
The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight
April 03, 2021
From Benzinga
From Benzinga
3 Healthcare Stocks That Could Be Millionaire-Makers
March 24, 2021
From Motley Fool
3 Undervalued Biotechs Worth Adding to Your Watch List
February 27, 2021
From Motley Fool
Supernus Pharmaceuticals Inc (SUPN) Q4 2020 Earnings Call Transcript
February 26, 2021
Tickers
SUPN
From Motley Fool
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
February 26, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 25, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
February 10, 2021
From Benzinga
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO
January 28, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
January 27, 2021
From Benzinga
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
January 26, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
January 20, 2021
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 15, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.